摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-(+)-homolaudanosine | 85611-40-1

中文名称
——
中文别名
——
英文名称
(S)-(+)-homolaudanosine
英文别名
(+)-Homolaudanosine;(S)-Homolaudanosine;(1S)-1-[2-(3,4-dimethoxyphenyl)ethyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinoline
(S)-(+)-homolaudanosine化学式
CAS
85611-40-1
化学式
C22H29NO4
mdl
——
分子量
371.477
InChiKey
AECKSTRRHRODOS-SFHVURJKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    481.1±45.0 °C(Predicted)
  • 密度:
    1.087±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    27
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    40.2
  • 氢给体数:
    0
  • 氢受体数:
    5

SDS

SDS:b25aab3796b9139ac038ba3d6672918d
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (S)-(+)-homolaudanosine 在 三氟代氧化钒(V) 、 氟磺酸三氟乙酸酐 作用下, 以40%的产率得到(+)-Homoglaucine
    参考文献:
    名称:
    An asymmetric synthesis of aporphine and related alkaloids via chiral formamidines. (+)-glaucine, (+)-homoglaucine, and (-)-8,9-didemethoxythalisopavine
    摘要:
    DOI:
    10.1021/jo00308a029
  • 作为产物:
    描述:
    3,4-二甲氧基肉桂酸Noyori's catalyst硼酸三(2,2,2-三氟乙基)酯 、 palladium 10% on activated carbon 、 氢气 、 sodium formate 、 sodium cyanoborohydride 、 zinc(II) chloride 、 三氯氧磷 作用下, 以 甲醇乙醇N,N-二甲基甲酰胺乙腈 为溶剂, 反应 78.17h, 生成 (S)-(+)-homolaudanosine
    参考文献:
    名称:
    仿生总生物碱。
    摘要:
    使用仿生方法,由花椒苷酰胺原生物碱实现了Dysoxylum生物碱的五步全合成。该合成具有直接酰胺化和Bischler-Napieralski反应形成二氢异喹啉环的特征,然后将其进行Noyori不对称转移氢化,以在C-1处建立立体异构中心。我们的合成序列为Dysoxylum生物碱的生物合成起源提供了重要的视角,因为获得了6种天然生物碱和12种合成类似物,具有很高的对映选择性,总收率高达68%。此外,我们描述了Dysoxylum生物碱对斑马鱼胚胎的急性毒性,将它们的毒性与相应的zanthoxylamide原生物碱的毒性进行了比较,并建立了对映选择性-毒性关系。
    DOI:
    10.1021/acs.joc.9b02093
点击查看最新优质反应信息

文献信息

  • Enantioselective synthesis of isoquinoline alkaloids: phenylethylisoquinoline and aporphine alkaloids
    作者:Zbigniew Czarnocki、David B. MacLean、Walter A. Szarek
    DOI:10.1139/v87-393
    日期:1987.10.1
    A new and improved procedure for the preparation of (R)-2-alkoxycarbonyl-1-formyl-1,2,3,4-tetrahydro-6,7-dimethoxyisoquinolines has been developed beginning from D-(−)-tartaric acid. The utility of these aldehydes in the asymmetric synthesis of isoquinoline alkaloids of high enantiomeric purity has been extended to the synthesis of phenylethylisoquinolines, which have been further transformed in straightforward
    从 D-(-)-酒石酸开始,开发了一种新的改进方法,用于制备 (R)-2-alkoxycarbonyl-1-formyl-1,2,3,4-四氢-6,7-二甲氧基异喹啉。这些醛在高对映体纯度的异喹啉生物碱的不对称合成中的用途已扩展到苯乙基异喹啉的合成,后者已通过直接步骤进一步转化为高原小檗碱和高卟啉环系统。以这种方式,已经合成了 (S)-高莫拉丹苷、(S)-5'-甲氧基高莫拉丹苷、(S)-2,3,9,10,11-五甲氧基高原小檗碱和 (S)-O-methylkreysigine。(S)-laudanosine 转化为 (S)-glaucine,一种阿朴啡生物碱,也已实现。
  • Asymmetric synthesis of six tetrahydroisoquinoline natural products through α-amination of an aldehyde
    作者:Anas Ansari、Amol B. Gorde、Ramesh Ramapanicker
    DOI:10.1016/j.tet.2021.132121
    日期:2021.5
    An enantioselective route towards the synthesis of C-1 substituted tetrahydroisoquinoline natural products is reported. Six different natural products are synthesized from a single aldehyde using proline-catalyzed asymmetric α-hydrazination reaction as the key step. The highly enantioselective introduction of an amino group is exploited to synthesize (−)-calycotomine, (−)-salsolidine, (−)-carnegine
    报道了合成C-1取代的四氢异喹啉天然产物的对映选择性途径。以脯氨酸催化的不对称α-酰化反应为关键步骤,由单一醛合成六种不同的天然产物。利用氨基的高度对映选择性引入来合成(-)-花椰菜碱,(-)-沙丁胺碱,(-)-肉碱,(+)-高麦芽糖苷,(+)-高原小ber碱和(+)-crispineA。
  • Recent progress using chiral formamidines in asymmetric syntheses
    作者:A.I. Meyers
    DOI:10.1016/s0040-4020(01)88523-9
    日期:1992.3
    The ability to generate a carbanion next to nitrogen in a chiral environment has led to a number of useful asymmetric routes to alkaloids and related substances. Mechanistic studies have been conducted to understand the nature of these alkylations.
    在手性环境中,在氮旁边生成碳负离子的能力导致了许多有用的不对称途径生成生物碱和相关物质。已经进行了机理研究以了解这些烷基化的性质。
  • Catalytic Asymmetric Allylation of 3,4-Dihydroisoquinolines and Its Application to the Synthesis of Isoquinoline Alkaloids
    作者:Michiko Miyazaki、Nami Ando、Keita Sugai、Yuki Seito、Hiromi Fukuoka、Takuya Kanemitsu、Kazuhiro Nagata、Yuki Odanaka、Kazuo T. Nakamura、Takashi Itoh
    DOI:10.1021/jo101956m
    日期:2011.1.21
    1-allyltetrahydroisoquinoline derivatives in good yield and stereoselectivity. The allyl adduct thus obtained was applied to the synthesis of several isoquinoline alkaloids such as crispine A and homolaudanosine. The reaction was further used for the synthesis of the isoquinoline moiety of schulzeine A.
    在DTBM-SEGPHOS作为手性配体的情况下,以烯丙基三甲氧基硅烷-Cu作为亲核试剂进行3,4-二氢异喹啉的催化不对称烯丙基化,以良好的收率和立体选择性提供相应的手性1-烯丙基四氢异喹啉衍生物。将由此获得的烯丙基加合物用于几种异喹啉生物碱的合成,如crispine A和homlaudanosine。该反应进一步用于合成舒尔西宁A的异喹啉部分。
  • Asymmetric synthesis of isoquinoline alkaloids
    作者:A.l. Meyers、Daniel A. Dickman、Michael Boes
    DOI:10.1016/s0040-4020(01)87686-9
    日期:1987.1
    to variously substituted tetrahydroisoquinolines, allows asymmetric C-C bond forming reactions to occur α- to the amino group. In this manner, a wide variety of (S)-1-alkyl-1,2,3,4-tetrahydroisoquinolines were constructed in > 90% enantiomeric excess. Choosing the proper substituents and skeletal features, an efficient entry into the benzylisoquinoline, tetrahydroprotoberberine, aporphine, and isopavine
    通过使用固定在各种取代的四氢异喹啉上的手性甲am,可以使氨基的α-发生不对称的CC键形成反应。以这种方式,以> 90%的对映体过量构造了各种各样的(S)-1-烷基-1,2,3,4-四氢异喹啉。选择合适的取代基和骨架特征,可以有效地进入苄基异喹啉,四氢小ber碱,阿福啡和异戊烷类生物碱。
查看更多

同类化合物

1-<2-(4-羟基-3-甲氧基)乙基>-7-羟基-6-甲氧基-1,2,3,4-四氢异喹啉 (1R)-1-(4-methoxyphenyl)-2-<(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol (1R)-1-(4-methoxyphenyl)-2-<(1S)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol (1S)-1-(4-methoxyphenyl)-2-<(1S)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol (1S)-1-(4-methoxyphenyl)-2-<(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol Isoautumnaline 6-benzyloxy-1-(3-benzyloxy-4,5-dimethoxyphenethyl)-7-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline 7-Benzyloxy-6-methoxy-2-methyl-1-(4-methoxy-phenethyl)-1,2,3,4-tetrahydro-isochinolin 1-(4-methoxyphenethyl)-1,2,3,4-tetrahydro-6-methoxy-2-methyl-7-isoquinolinol (+)-colchiethine 7-hydroxy-6-methoxy-1-(3',4',5'-trimethoxyphenethyl)-N-methyl-1,2,3,4-tetrahydroisoquinoline (+)-colchiethanamine (+/-)-N,N-Dimethyl-6,7,3',4'-tetramethoxyphenylethyl-1,2,3,4-tetrahydroisoquinolinium iodide [(1S)-7-methoxy-1-[2-(4-methoxyphenyl)ethyl]-2-methyl-3,4-dihydro-1H-isoquinolin-6-yl] 2,2-dimethylpropanoate [4-[2-[(1S)-6-(2,2-dimethylpropanoyloxy)-7-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]ethyl]phenyl] 2,2-dimethylpropanoate (1S)-6,7-dimethoxy-2-methyl-1-[2-(3,4,5-trimethoxyphenyl)ethyl]-1,2,3,4-tetrahydroisoquinoline (S)-autumnaline 6,7-dimethoxy-1-(4-methoxyphenylethyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline 1,2,3,4-tetrahydro-6-hydroxy-7-methoxy-1-(2-(3',4'-dimethoxyphenyl)ethyl)-2-methylisoquinoline (S)-(+)-homolaudanosine (-)-Homolaudanosine (1R)-1-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol (1S)-1-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-7-ol (1S)-1-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-7-ol (1R)-1-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol (1S)-1-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol (S)-1-[2-(4-Hydroxy-phenyl)-ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-7-ol (1R)-1-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-7-ol (1R)-1-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-7-ol (1S)-1-[2-(4-hydroxy-3,5-dimethoxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol N-Methyl-1-(3,5-dimethoxy-4-hydroxy-phenethyl)-2-methyl-7-hydroxy-6-methoxy-1,2,3,4-tetrahydro-isochinolin (1R)-1-[2-(4-hydroxy-3,5-dimethoxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol (1S)-1-[2-[4-[[(1R)-1-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]phenyl]ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol 1-{2-[4-({1-[2-(4-Hydroxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl}oxy)phenyl]ethyl}-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol 1-[2-(4-hydroxyphenyl)ethyl]-7-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-6-ol 7-Hydroxy-1-(3-hydroxy-4,5-dimethoxy-phenethyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydro-isochinolin 7-Hydroxy-1-(4-hydroxy-phenethyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydro-isochinolin, 1-<2-(p-Hydroxy-phenyl)-ethyl>-2-methyl-6-methoxy-7-hydroxy-1,2,3,4-tetrahydro-isochinolin (+/-)-isoautumnaline homolaudanosine 7-methoxy-1-(4-methoxyphenylethyl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-6-ol